AGP Picks
View all

Middle East FinTech today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Middle East FinTech today.

Press releases published on November 18, 2026

Belgravia International Highlights Edgware Road as a Prime London Residential Destination
WorldVest Launches MineralVC Partners, Opening Sidecar Co-Investment Access to MineralVest Global Mineral Ventures
Novel Direct-to-Brain Intracerebroventricular Stem Cell Phase 1 Trial Shows Safety and Exciting Results in Alzheimer’s
SilberArrows Publishes Guidance on Independent Mercedes-Benz Servicing Options
DIAGEN AI, INC. PARTNERS WITH NASDAQ:MEDS TO DISCOVER NOVEL CANCER TARGETS & DEVELOP ANTI-CANCER PEPTIDE PIPELINE
Banking is 'a catalyst' for Bahrain’s diversification, says GIB B.S.C  CEO
AmericanAI Launches Global Authorized Training Partner Program to Expand Executive AI Education Worldwide
Yubi Launches Pye to Make UAE Mortgages Effortless
Code Effects Releases Version 7 with Secure AI Agents, Rule Governance, and Auditing for .NET
Suffolk County Public Adjuster for Storm and Shoreline Claims, Republic Claims Associates, Opens Claim Reviews as New York Seeks Federal Repairs to Fire Island-to-Montauk Coastal Projects
ريد ألباين، تُغلق صندوقاً بقيمة 250 مليون دولار أمريكي، وترى في الإمارات شريكاً طبيعياً للتكنولوجيا العميقة الأوروبية
The Surety & Fidelity Association of America Foundation Awards Record 50 Scholarships
Millicom (Tigo) announces upsize and pricing of Senior Notes due 2033   
Loblaw November Food Inflation Report
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Northrop Grumman Board Declares Quarterly Dividend
REEcycle Holdings, Inc. and Hall Chadwick Acquisition Corp. Announce Additional $15.0 Million PIPE Commitments from Leading Institutional Stockholders
redalpine, backer of Proxima Fusion, closes USD 250 million fund, sees UAE as natural partner for European deeptech
Press Release: Sanofi’s Infilbray approved in the US as the first medicine to treat neurological manifestations of Type 3 Gaucher disease
Communiqué de presse : Infilbray, de Sanofi, approuvé aux États-Unis comme le premier médicament indiqué dans le traitement des manifestations neurologiques de la maladie de Gaucher de type 3

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Middle East FinTech today

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.